Behçet's disease exhibits an increased osteopontin serum level in active stage but no association with osteopontin and its receptor gene polymorphisms

Human Immunology

Volumn 72, Issue 6, 2011, Pages 525-529

  Chu, Mingliang ^a,b   Yang, Peizeng ^b   Hou, Shengping ^b   Li, Fuzhen ^b   Chen, Yuanyuan ^b   Kijlstra, Aize ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Beh et's disease; Osteopontin; Single nucleotide polymorphism

Indexed keywords

OSTEOPONTIN;

ADULT; ALLELE; ARTICLE; BEHCET DISEASE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANTIGENS, CD44; BEHCET SYNDROME; CHINA; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INTEGRINS; MALE; OSTEOPONTIN; POLYMORPHISM, GENETIC;

EID: 79955771075     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.03.016     Document Type: Article

References (38)

1. Sakane T., Takeno M., Suzuki N., Inaba G. Behçet's disease. N Engl J Med 1999, 341:1284-1291.
2. Gül A. Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005, 4:81-83.
3. Wang K.X., Denhardt D.T. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev 2008, 19:333-345.
4. Murugaiyan G., Mittal A., Weiner H.L. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4(+) T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J Immunol 2008, 181:7480-7488.
5. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Jansson M., Zawaideh S., et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000, 287:860-864.
6. Chen G., Zhang X., Li R., Zhang J.Z., China S., Niu X., et al. Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritis. Arthritis Rheum 2010, 62:2900-2908.
7. Ohno S., Kato F., Matsuda H., Fujii N., Minagawa T. Studies on spontaneous production of gamma-interferon in Behçet's disease. Ophthalmologica 1982, 185:187-192.
8. Chi W., Zhu X., Yang P., Liu X., Lin X., Zhou H., et al. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci 2008, 49:3058-3064.
9. Agnholt J., Kelsen J., Schack L., Hvas C.L., Dahlerup J.F., Sorensen E.S. Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease. Scand J Immunol 2007, 65:453-460.
10. Comabella M., Pericot I., Goertsches R., Nos C., Castillo M., Blas Navarro J., et al. Plasma osteopontin levels in multiple sclerosis. J Neuroimmunol 2005, 158:231-239.
11. Sennels H., Sørensen S., Ostergaard M., Knudsen L., Hansen M., Skjødt H., et al. Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate. Scand J Rheumatol 2008, 37:241-247.
12. Wong C.K., Lit L.C.W., Tam L.S., Li E.K., Lam C.W.K. Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005, 44:602-606.
13. O'Doherty C., Roos I.M., Antiguedad A., Aransay A.M., Hillert J., Vandenbroeck K. ITGA4 polymorphisms and susceptibility to multiple sclerosis. J Neuroimmunol 2007, 189:151-157.
14. Niino M., Kikuchi S., Fukazawa T., Yabe I., Tashiro K. Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients. J Neuroimmunol 2003, 136:125-129.
15. Hollis-Moffatt J.E., Rowley K.A., Phipps-Green A.J., Merriman M.E., Dalbeth N., Gow P., et al. The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets. Arthritis Res Ther 2009, 11:R152.
16. D'Alfonso S., Barizzone N., Giordano M., Chiocchetti A., Magnani C., Castelli L., et al. Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2005, 52:539-547.
17. Weiss L.A., Lester L.A., Gern J.E., Wolf R.L., Parry R., Lemanske R.F., et al. Variation in ITGB3 is associated with asthma and sensitization to mold allergen in four populations. Am J Respir Crit Care 2005, 172:67-73.
18. Thompson E.E., Pan L., Ostrovnaya I., Weiss L.A., Gern J.E., Lemanske R.F., et al. Integrin beta 3 genotype influences asthma and allergy phenotypes in the first 6 years of life. J Allergy Clin Immunol 2007, 119:1423-1429.
19. Mathias R.A., Gao P., Goldstein J.L., Wilson A.F., Pugh E.W., Furbert-Harris P., et al. A graphical assessment of p-values from sliding window haplotype tests of association to identify asthma susceptibility loci on chromosome 11q. BMC Genet 2006, 7:38.
20. Kitamura M., Iwabuchi K., Kitaichi N., Kon S., Kitamei H., Namba K., et al. Osteopontin aggravates experimental autoimmune uveoretinitis in mice. J Immunol 2007, 178:6567-6572.
21. Hikita S.T., Vistica B.P., Jones H.R., Keswani J.R., Watson M.M., Ericson V.R., et al. Osteopontin is proinflammatory in experimental autoimmune uveitis. Invest Ophth Vis Sci 2006, 47:4435-4443.
22. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's disease. Lancet 1990, 335:1078-1080.
23. Hamzaoui K., Hamzaoui A., Guemira F., Bessioud M., Hamza M., et al. Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol 2002, 31:205-210.
24. de Menthon M., Lavalley M.P., Maldini C., Guillevin L., Mahr A. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009, 61:1287-1296.
25. Verity D.H., Marr J.E., Ohno S., Wallace G.R., Stanford M.R. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999, 54:213-220.
26. Kamoun M., Chelbi H., Houman M.H., Lacheb J., Hamzaoui K. Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease. Hum Immunol 2007, 68:201-205.
27. Kamoun M., Ben Dhifallah I., Karray E., Zakraoui L., Hamzaoui K. Association of small ubiquitin-like modifier 4 (SUMO4) polymorphisms in a Tunisian population with Behçet's disease. Clin Exp Rheumatol 2010, 28:S45-S49.
28. Remmers E.F., Cosan F., Kirino Y., Ombrello M.J., Abaci N., Satorius C., et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet 2010, 42:698-702.
29. Mizuki N., Meguro A., Ota M., Ohno S., Shiota T., Kawagoe T., et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet 2010, 42:703-706.
30. Lund S.A., Giachelli C.M., Scatena M. The role of osteopontin in inflammatory processes. J Cell Commun Signal 2009, 3:311-322.
31. Marciano R., D'Annunzio G., Minuto N., Pasquali L., Santamaria A., Di Duca M., et al. Association of alleles at polymorphic sites in the osteopontin encoding gene in young type 1 diabetic patients. Clin Immunol 2009, 131:84-91.
32. Han S., Guthridge J.M., Harley I.T.W., Sestak A.L., Kim-Howard X., Kaufman K.M., et al. Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction. PLoS One 2008, 3:e0001757.
33. Hensiek A.E., Roxburgh R., Meranian M., Seaman S., Yeo T., Compston D.A., et al. Osteopontin gene and clinical severity of multiple sclerosis. J Neurol 2003, 250:943-947.
34. Forton A.C., Petri M.A., Goldman D., Sullivan K.E. An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Hum Mutat 2002, 19:459.
35. Liu C.C., Huang S.P., Tsai L.Y., Wu W.J., Juo S.H., Chou Y.H., et al. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis. Clin Chim Acta 2010, 411:739-743.
36. Zimrin A.B., Gidwitz S., Lord S., Schwartz E., Bennett J.S., White G.C., et al. The genomic organization of platelet glycoprotein IIIa. J Biol Chem 1990, 265:8590-8595.
37. Jakubowska A., Gronwald J., Menkiszak J., Górski B., Huzarski T., Byrski T., et al. Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk. J Med Genet 2007, 44:408-411.
38. Xu G., Sun W., He D., Wang L., Zheng W., Nie H., et al. Overexpression of osteopontin in rheumatoid synovial mononuclear cells is associated with joint inflammation, not with genetic polymorphism. J Rheumatol 2005, 32:410-416.